-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HqlL6GLVxthdvKvgztxMoXdnuF1Drvq48ND2p/sEgsGb3Ib1oxV1/u8ctI9f+sbY YaPicJ6w/BOxmk+2cJFp9A== 0001047469-04-029693.txt : 20040927 0001047469-04-029693.hdr.sgml : 20040927 20040927162537 ACCESSION NUMBER: 0001047469-04-029693 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040927 DATE AS OF CHANGE: 20040927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 041047513 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 8-A12G 1 a2144050z8-a12g.htm 8-A12G
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934

THERAVANCE, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State of
Incorporation or Organization)
  94-3265960
(I.R.S. Employer
Identification Number)

901 Gateway Boulevard
South San Francisco, California
(Address of Principal Executive Offices)

 

  
94080
(Zip Code)

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. o

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ý


   

Securities Act registration statement file number to which this form relates:   333-116384
(If applicable)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of Each Class
to be so Registered

Name of Each Exchange on Which
Each Class is to be Registered

Not Applicable Not Applicable

Securities to be registered pursuant to Section 12(g) of the Act:

Common Stock, $0.01 par value, and associated Preferred Stock Purchase Rights
(Title of class)



Item 1.    Description of Registrant's Securities to be Registered.

      Incorporated herein by reference to the Description of Capital Stock section of the Registrant's Registration Statement on Form S-1 (File No. 333-116384) (the "S-1 Registration Statement").


Item 2.    Exhibits.

 
  Exhibit
Number

  Description
    1.1   Restated Certificate of Incorporation of the Registrant (currently in effect) (incorporated herein by reference to Exhibit 3.1 to the S-1 Registration Statement).

 

 

1.2

 

Form of Amended and Restated Certificate of Incorporation of the registrant effecting a reverse stock split to take effect prior to the effectiveness of the S-1 Registration Statement (incorporated herein by reference to Exhibit 3.2 to the S-1 Registration Statement).

 

 

1.3

 

Form of Amended and Restated Certificate of Incorporation of the Registrant to take effect upon the closing of the offering made pursuant to the S-1 Registration Statement (incorporated herein by reference to Exhibit 3.3 to the S-1 Registration Statement).

 

 

1.4

 

Bylaws of the Registrant (currently in effect) (incorporated herein by reference to Exhibit 3.4 to the S-1 Registration Statement).

 

 

1.5

 

Form of Amended and Restated Bylaws of the Registrant to take effect upon the closing of the offering made pursuant to the S-1 Registration Statement (incorporated herein by reference to Exhibit 3.5 to the S-1 Registration Statement).

 

 

1.6

 

Specimen Certificate of the Registrant's common stock (incorporated herein by reference to Exhibit 4.1 to the S-1 Registration Statement).

 

 

1.7

 

Form of Rights Agreement of the Registrant to be effective upon the closing of the offering made pursuant to the S-1 Registration Statement (incorporated herein by reference to Exhibit 4.2 to the S-1 Registration Statement).


SIGNATURE

        Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

  THERAVANCE, INC.

Date: September 27, 2004

By:

/s/  
RICK E WINNINGHAM      
Rick E Winningham
Chief Executive Officer


EXHIBITS

Exhibit
Number

  Description
1.1   Restated Certificate of Incorporation of the Registrant (currently in effect) (incorporated herein by reference to Exhibit 3.1 to the S-1 Registration Statement).

1.2

 

Form of Amended and Restated Certificate of Incorporation of the registrant effecting a reverse stock split to take effect prior to the effectiveness of the S-1 Registration Statement (incorporated herein by reference to Exhibit 3.2 to the S-1 Registration Statement).

1.3

 

Form of Amended and Restated Certificate of Incorporation of the Registrant to take effect upon the closing of the offering made pursuant to the S-1 Registration Statement (incorporated herein by reference to Exhibit 3.3 to the S-1 Registration Statement).

1.4

 

Bylaws of the Registrant (currently in effect) (incorporated herein by reference to Exhibit 3.4 to the S-1 Registration Statement).

1.5

 

Form of Amended and Restated Bylaws of the Registrant to take effect upon the closing of the offering made pursuant to the S-1 Registration Statement (incorporated herein by reference to Exhibit 3.5 to the S-1 Registration Statement).

1.6

 

Specimen Certificate of the Registrant's common stock (incorporated herein by reference to Exhibit 4.1 to the S-1 Registration Statement).

1.7

 

Form of Rights Agreement of the Registrant to be effective upon the closing of the offering made pursuant to the S-1 Registration Statement (incorporated herein by reference to Exhibit 4.2 to the S-1 Registration Statement).



QuickLinks

SIGNATURE
EXHIBITS
-----END PRIVACY-ENHANCED MESSAGE-----